Global Soft Tissue Allografts Market: Overview
This report on the soft tissue allografts market analyzes the current and future scenario of the global market. Large number of ACL injury patient and diabetes sufferers is increasing the usage of soft tissue allografts. Increasing prevalence of degenerative joint diseases and high definition designed technology are the major drivers of the global soft tissue allografts market.
The soft tissue allografts market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on soft tissue allograft type, application, end user and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises porters five force analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global soft tissue allografts market.
Global Soft Tissue Allografts Market: Segmentations
Based on soft tissue allograft type, the market has been segmented into cartilage allograft (hyaline cartilage; elastic cartilage; fibro cartilage); tendon allograft (achilles tendon; tibialis; patellar tendon); meniscus allograft; dental allograft (free gingival graft; connective tissue graft; pedicle graft); collagen allograft; amniotic allograft. The soft tissue allograft type market segments have been analyzed based on available approved products, cost-effectiveness, and preference for technologies by orthopaedic, dental & aesthetic surgeons, and patients. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.
Based on end-user, the soft tissue allografts market has been segmented into five major categories: hospitals, ambulatory surgical centers, aesthetic clinics, orthopaedic clinics and dental clinics. The soft tissue allografts market is also segmented into application, including orthopaedic (sports medicine; spine injuries; general Orthopaedic; reconstruction), dentistry (dental sensitivity; aesthetics), wound care, and others. The market segments have been extensively analyzed based on prevalence of the diseases, available treatment, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.
Geographically, the global soft tissue allografts market has been categorized into six major regions and the key countries in the respective region: North America (the U.S., Canada), Western Europe (the U.K., Germany, France, Spain, Italy, and Rest of Western Europe), Eastern Europe (Russia, Poland, and Rest of Eastern Europe), Asia Pacific (Japan, India, China, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.
Global Soft Tissue Allografts Market: Competitive Landscape
The report also profiles major players in the global soft tissue allografts market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include Allergan, plc; Lattice Biologics Ltd.; Zimmer Biomet; AlonSource Group; MiMedix Group; AlloSource; CONMED Corporation; Organogenesis Inc.; RTI Surgical, Inc; Osiris Therapeutics; Integra LifeSciences Corporation; Globus Medical Inc; Straumann Holding AG; Xtant Medical; Alliqua BioMedical, Inc; C. R. Bard, Inc (Davol Inc); B. Braun Melsungen AG; Bone Bank Allograft; Arthrex; and Others.
Global soft tissue allografts market is segmented as below: